Pyrazole derivatives as inhibitors of arachidonic acid-induced platelet aggregation
- 1 June 2013
- journal article
- Published by Elsevier BV in European Journal of Medicinal Chemistry
- Vol. 64, 42-53
- https://doi.org/10.1016/j.ejmech.2013.03.048
Abstract
No abstract availableKeywords
Funding Information
- Scientific Research (110S106)
This publication has 26 references indexed in Scilit:
- New antiplatelet agents: Why they are neededEuropean Journal of Internal Medicine, 2009
- Antiplatelet therapies and the role of antiplatelet resistance in acute coronary syndromeThrombosis Research, 2009
- Mechanisms of platelet activation: Need for new strategies to protect against platelet-mediated atherothrombosisThrombosis and Haemostasis, 2009
- Prevention of Premature Discontinuation of Dual Antiplatelet Therapy in Patients With Coronary Artery StentsCirculation, 2007
- Antiplatelet Drug Resistance and Drug-Drug Interactions: Role of Cytochrome P450 3A4Pharmaceutical Research, 2006
- Aspirin and Clopidogrel ResistanceMayo Clinic Proceedings, 2006
- Aspirin resistanceThe Lancet, 2006
- Review of Antiplatelet Therapy in Secondary Prevention of Cerebrovascular Events: A Need for Direct Comparisons Between Antiplatelet AgentsJournal of Cardiovascular Pharmacology and Therapeutics, 2005
- Pyridazines. Part 36: Synthesis and antiplatelet activity of 5-substituted-6-phenyl-3(2H)-pyridazinonesBioorganic & Medicinal Chemistry Letters, 2003
- Antiplatelet therapyThe American Journal of Medicine, 1996